Silo Pharma Completes Successful Dose-Ranging Study of
All animal subjects tolerated maximum dosing Once-per-day human intranasal dosing regimen determined for clinical evaluation SARASOTA, FL, Feb. 28, 2024...
Source: globenewswire.com
Nasdaq Silo News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nasdaq Silo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nasdaq Silo Today - Breaking & Trending Today
Silo Pharma Announces Positive Results in Alzheimer's
Preclinical study shows SPC-14’s effectiveness against LH (luteinizing hormone) stress, helplessness, and anxiety. SARASOTA, FL, Jan. 24, 2024 (GLOBE...
Source: globenewswire.com
Silo Pharma Successfully Completes First Phase of
Final validation report expected in first quarter 2024 ENGLEWOOD CLIFFS, NJ, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo”...
Source: globenewswire.com
Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Update
Silo Pharma, Inc. (NASDAQ:SILO – Get Free Report) was the recipient of a large drop in short interest in December. As of December 15th, there was short interest totalling 55,800 shares, a drop of 28.7% from the November 30th total of 78,300 shares. Approximately 2.2% of the shares of the stock are sold short. Based […]
Source: etfdailynews.com
Silo Pharma's SPU-21 Peptide Shows Positive Results Against
Human tissue study assessed SPU-21’s efficiency, optimization, and binding affinity ENGLEWOOD CLIFFS, NJ, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Silo...
Source: globenewswire.com